Austrálie - angličtina - Department of Health (Therapeutic Goods Administration)

device technologies australia pty ltd - 17471 - suture, polyglactin - an absorbable, braided, synthetic suture composed of a co-polymer made from 90% glycolide and 10% lactide attached to a stainless steel needles of varying types and sizes. progressive loss of tensile strength and eventual absorption occurs by means of hydrolysis. absorption begins as a loss of tensile strength followed by loss of mass all of the original tensile strength is lost between 4 and 5 weeks post implantation. an absorbable suture intended for general soft tissue approximation and/or ligation, including use in ophthalmic surgery, peripheral nerve anastomosis and microsurgery for vessels less than 2mm diameter.

Singapur - angličtina - HSA (Health Sciences Authority)

scient'x asia pacific pte. ltd. - orthopaedics - intended for spinal fusion procedures in skeletally mature patients with degenerative disc disease (ddd) at one or two contiguous levels from l2- s1 with up to grade 1 spondylolisthesis or retrolisthesis at the involved level(s). ddd is defined as back pain of discogenic origin with degeneration of the disc confirmed by history and radiographic studies. these patients should be skeletally mature and have had six months of non-operative treatment. the solus implant is intended to be used with autograft.

Spojené státy - angličtina - NLM (National Library of Medicine)

solus rx, llc - exudate amounts: none, low or moderate. do not use on wounds with highamount of exudate. solox gel™ is indicated for partial and full thickness wounds including pressure ulcers, venous stasis ulcers, diabetic ulcers, first and second degree bums, abrasions, lacerations, skin tears, grafted wounds, donor sites and surgical wounds.    solox gel™ is contraindicated to persons with allergies to any of the ingredients.

Spojené státy - angličtina - NLM (National Library of Medicine)

solus rx, llc - deluo™ antimicrobial wound & skin cleanser is indicated for management of wounds such as stage i-iv pressure ulcers, partial and full thickness wounds, diabetic foot and leg ulcers, post-surgical wounds, first and second-degree burns, grafted and donor sites, and minor irritations of the skin in addition to moistening and lubricating absorbent wound dressings.

Zimbabwe - angličtina - Medicines Control Authority

caps pvt ltd - streptomycin sulphate - injectable; injection - 330mg/ml

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

resmed healthcare - tablet - see ingredients - tablet aspirin 300 mg

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

caps pharmaceuticals sa (pty) ltd - injection - each 1 ml solution contains streptomycin sulphate equivalent to streptomycin 330 mg

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

resmed healthcare - tablet - see ingredients - each tablet contains aspirin 100,0 mg

Jihoafrická republika - angličtina - South African Health Products Regulatory Authority (SAHPRA)

resmed healthcare - #n/a - not indicated - none

Namibie - angličtina - Namibia Medicines Regulatory Council

caps pharmaceuticals (sa) (pty) ltd - streptomycin sulphate - injectable solution - each 1ml injection contains streptomycin sulphate equivalent to 330 mg streptomycin base